National Peroxide Falls to 52-Week Low of Rs.511 Amidst Prolonged Downtrend

Stock Price Movement and Market Context

On 1 Dec 2025, National Peroxide's share price touched an intraday low of Rs.511, representing a decline of approximately 2.48% during the trading session. This level also stands as the stock's all-time low, underscoring the extent of the recent price erosion. Despite this, the stock showed some resilience by gaining after two consecutive days of decline, though it remains below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning indicates a sustained bearish trend over multiple time horizons.

In contrast, the broader market environment has been relatively positive. The Sensex opened higher at 86,065.92 points, gaining 0.42% at the start of the day and trading near its 52-week high of 86,055.86. The index has recorded a 1.57% rise over the past three weeks and continues to trade above its 50-day moving average, which itself is positioned above the 200-day moving average—signals typically associated with bullish momentum. Small-cap stocks have also led gains, with the BSE Small Cap index advancing by 0.4% today.

Financial Performance and Profitability Trends

National Peroxide's financial metrics over recent years and quarters provide insight into the challenges faced by the company. The stock's one-year performance shows a decline of 38.51%, markedly underperforming the Sensex's 7.62% gain over the same period. The 52-week high for the stock was Rs.907.30, highlighting the scale of the price contraction.

Operating profits have shown a negative compound annual growth rate (CAGR) of 135.58% over the last five years, indicating a persistent contraction in core earnings. The company's ability to service debt remains constrained, with an average EBIT to interest ratio of 0.14, reflecting limited earnings relative to interest obligations. Return on equity (ROE) has averaged 1.90%, signalling modest profitability relative to shareholders' funds.

Recent results for the six months ending September 2025 reveal a profit after tax (PAT) of Rs.1.28 crore, which has declined by 77.78% compared to the previous period. Additionally, non-operating income for the quarter accounts for 263.49% of profit before tax (PBT), suggesting that earnings are increasingly reliant on sources outside the company’s primary business operations.

Valuation and Risk Considerations

The stock's valuation metrics suggest elevated risk relative to its historical averages. Over the past year, profits have contracted by 113%, while the stock price has declined by 38.51%. This disparity points to a challenging earnings environment that has weighed on investor sentiment. Furthermore, National Peroxide has underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, indicating sustained relative weakness.

Promoters remain the majority shareholders, maintaining control over the company’s strategic direction. However, the subdued financial indicators and price performance highlight ongoing concerns within the commodity chemicals sector, where National Peroxide operates.

Technical Indicators and Moving Averages

National Peroxide's share price currently trades below all major moving averages, including short-term (5-day, 20-day) and long-term (50-day, 100-day, 200-day) averages. This technical positioning typically reflects a bearish market sentiment and a lack of upward momentum. The stock’s recent intraday low of Rs.511 is a key technical level, representing both a 52-week and all-time low, which may act as a psychological barrier for market participants.

Despite the broader market’s positive tone, with the Sensex near its 52-week high and small caps leading gains, National Peroxide’s price action remains subdued. The divergence between the stock’s performance and the overall market highlights sector-specific or company-specific factors influencing investor behaviour.

Summary of Key Metrics

To summarise, National Peroxide’s stock has experienced a significant decline over the past year, with a 38.51% reduction in share price and a 113% contraction in profits. The company’s operating profit growth has been negative over five years, and its ability to cover interest expenses remains limited. Return on equity is modest, and recent earnings have shown a sharp decline. The stock’s current trading below all major moving averages further emphasises the prevailing downward trend.

While the Sensex and broader market indices have shown strength, National Peroxide’s performance remains an outlier within the commodity chemicals sector. The stock’s new 52-week low of Rs.511 marks a notable point in its price history, reflecting ongoing challenges in financial performance and market valuation.

Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →